Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension

Not Applicable

Withdrawn

• Conditions: Afib; Hypertension
• Interventions: Procedure: Renal Artery denervation

• Registration Number: NCT01952925
• Lead Sponsor: Oregon Health and Science University

Brief Summary

The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2013-09-25
• Study First Submitted QC: 2013-09-27
• Study First Posted: 2013-09-30
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-17
• Last Update Posted: 2019-02-19
• Study Start: 2019-03
• Primary Completion: 2019-03
• Study Completion: 2019-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Hypertensive patients scheduled for afib ablation
• Patient taking one or more BP medication

Read More

Exclusion Criteria

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Combined afib ablation and RA denervation	Renal Artery denervation	Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation.

Primary Outcome Measures

Name	Time	Method
change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments	1 to 3 months

Trial Locations

Locations (1)

Oregon Health & Science University; 🇺🇸 Portland, Oregon, United States